Evidence map›Paper›PMID 27194219›Full record

ReviewChembiochem : a European journal of chemical biology2016

The Oxygen Dilemma: A Severe Challenge for the Application of Monooxygenases?

Dirk Holtmann, Frank Hollmann

Open access · hybridAbstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 149 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Optimising COMicrobial cell factories · 2025
    Article
  4. Article
  5. High hydrostatic pressure stimulates n-CCommunications biology · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Light-driven biocatalytic oxidation.Chemical science · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Functional Expression of Two Unusual Acidic Peroxygenases fromApplied and environmental microbiology · 2021
    Article
  20. Pilot-Scale Production of Peroxygenase fromOrganic process research & development · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dirk HoltmannDECHEMA Research Institute, Theodor-Heuss-Allee 25, 60486, Frankfurt am Main, Germany.
Frank HollmannDepartment of Biotechnology, Delft University of Technology, Julianalaan 136, 2628BL, Delft, The Netherlands. f.hollmann@tudelft.nl.
DECHEMA-ForschungsinstitutDelft University of Technology · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monooxygenases are promising catalysts because they in principle enable the organic chemist to perform highly selective oxyfunctionalisation reactions that are otherwise difficult to achieve. For this, monooxygenases require reducing equivalents, to allow reductive activation of molecular oxygen at the enzymes' active sites. However, these reducing equivalents are often delivered to O2 either directly or via a reduced intermediate (uncoupling), yielding hazardous reactive oxygen species and wasting valuable reducing equivalents. The oxygen dilemma arises from monooxygenases' dependency on O2 and the undesired uncoupling reaction. With this contribution we hope to generate a general awareness of the oxygen dilemma and to discuss its nature and some promising solutions.

Indexed as

CatalysisChemistry, OrganicMixed Function OxygenasesOxidation-ReductionOxygenMixed Function OxygenasesOxygenbiocatalysismonooxygenasesoxidoreductasesoxyfunctionalizationuncoupling

Identifiers

PMID27194219
PMCPMC5096067
OpenAlexW2397536361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.